Table 2.
Management and outcomes (N=190)
| Cut-through hysterectomy | |
| No | 187 (98.4) |
| Yes | 3 (1.6) |
| Radical hysterectomy | |
| No | 134 (70.5) |
| Initial | 47 (24.7) |
| After RT/CT | 9 (4.7) |
| Radiotherapy | |
| No | 42 (22.1) |
| Initial | 119 (62.6) |
| Adjuvant | 29 (15.3) |
| Chemotherapy | |
| No | 63 (33.2) |
| Concurrent | 101 (53.2) |
| Adjuvant | 25 (13.2) |
| Systemic chemotherapy | |
| No | 178 (93.7) |
| Yes | 12 (6.3) |
| Palliative care | |
| No | 180 (94.7) |
| Yes | 9 (4.7) |
| Missing data | 1 (0.5) |
| Follow-up and outcome | |
| Total follow-up time (months) | 37.0 (46-62) |
| Persistent tumor | |
| Yes | 7 (3.7) |
| Recurrence | |
| Recurrence rate | 49 (25.8) |
| Time-to-recurrence (months) | 13.0 (6.0-28.0) |
| Mortality | |
| Mortality rate | 89 (46.8) |
| Time-to-death (months) | 20 (9.0-46.5) |
| 5-year follow-up status | |
| Alive without disease | 53 (27.9) |
| Alive with disease | 8 (4.2) |
| Deceased | 73 (38.4) |
| Unknown (FU<5 years) | 56 (29.5) |
Data are number (%) or median (IQR) unless noted otherwise. Because of missing data, not all values sum to the total.